戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 lagellin, respectively, all could facilitate anti-glomerular Ab-elicited nephritis.
2 e receive nephrotoxic serum (NTS) containing anti-glomerular antibodies.
3         Two different proliferative forms of anti-glomerular basal membrane (GBM) GN in rats were ind
4 ession of HB-EGF in rat kidneys treated with anti- glomerular basement membrane (anti-GBM) antibody (
5 partment developed glomerulonephritis in the anti-glomerular basement disease model, whereas nontrans
6                 Urine samples from mice with anti-glomerular basement membrane (anti-GBM) antibody-in
7 als investigating treatments and outcomes in anti-glomerular basement membrane (anti-GBM) disease are
8                       The pathophysiology of anti-glomerular basement membrane (anti-GBM) disease bef
9 roblast recruitment in renal fibrosis due to anti-glomerular basement membrane (anti-GBM) disease is
10                                              Anti-glomerular basement membrane (anti-GBM) disease is
11  their kidneys as a result of posttransplant anti-glomerular basement membrane (anti-GBM) disease.
12                                          The anti-glomerular basement membrane (GBM) Ab has been rega
13 poor in patients presenting with circulating anti-glomerular basement membrane (GBM) antibodies and s
14  immunoperoxidase assay on cell layers using anti-glomerular basement membrane (GBM) antibodies.
15 l chemoattractant, during the progression of anti-glomerular basement membrane (GBM) antibody (Ab) GN
16                                              Anti-glomerular basement membrane (GBM) antibody nephrit
17 f inflammation and in the progression of the anti-glomerular basement membrane (GBM) antibody-induced
18                                              Anti-glomerular basement membrane (GBM) disease is a rap
19                           Most patients with anti-glomerular basement membrane (GBM) disease present
20                                        Human anti-glomerular basement membrane (GBM) disease strongly
21      We developed a new mouse model of human anti-glomerular basement membrane (GBM) disease to bette
22            We developed a rat model of human anti-glomerular basement membrane (GBM) disease to inves
23 obulin G (IgG) and complement C3, typical of anti-glomerular basement membrane (GBM) disease.
24 ere, macrophage-mediated, cytokine-dependent anti-glomerular basement membrane (GBM) glomerulonephrit
25 inflammation, the development of accelerated anti-glomerular basement membrane (GBM) glomerulonephrit
26  autologous phase of an accelerated model of anti-glomerular basement membrane (GBM) glomerulonephrit
27  in vivo, we induced a model of Fc-dependent anti-glomerular basement membrane (GBM) nephritis in wil
28                   Alport posttransplantation anti-glomerular basement membrane (GBM) nephritis is med
29 s to monitor renal disease progression in an anti-glomerular basement membrane (GBM) nephritis mouse
30 e subjected to an augmented passive model of anti-glomerular basement membrane (GBM)-induced experime
31 f glomerulonephritis induced by heterologous anti-glomerular basement membrane Abs in wild-type (IL-4
32 initiated by binding of heterologous (sheep) anti-glomerular basement membrane Abs to the glomeruli o
33 ls of experimental glomerulonephritis, being anti-glomerular basement membrane and lipopolysaccharide
34  distinct, separate disease process, such as anti-glomerular basement membrane antibodies or anti-neu
35 s characterized by circulating and deposited anti-glomerular basement membrane antibodies, focal necr
36 ies has been known to occur with exposure to anti-glomerular basement membrane antibody (AGBM-Ab) in
37 body (ANCA) vasculitis, lupus nephritis, and anti-glomerular basement membrane antibody GN.
38                           Injection of sheep anti-glomerular basement membrane antibody into preimmun
39                       In GEC(HO-1) rats with anti-glomerular basement membrane antibody mediated, com
40 lowing parameters both at baseline and after anti-glomerular basement membrane antibody treatment: bl
41 triggered GN with a subnephritogenic dose of anti-glomerular basement membrane antibody, Aire(-/-) mi
42 issolution of NETs via DNase I did not alter anti-glomerular basement membrane antibody-induced glome
43 ly modulates iNOS expression and activity in anti-glomerular basement membrane antibody-mediated glom
44 y immunizing mice with MPO and a low dose of anti-glomerular basement membrane antibody.
45 lonephritis induced by the administration of anti-glomerular basement membrane antibody.
46                 Introduction of heterologous anti-glomerular basement membrane antiserum (nephrotoxic
47 s induced with a previously described rabbit anti-glomerular basement membrane antiserum nephritis ap
48 mediated by pathogenic antibodies, including anti-glomerular basement membrane disease and lupus neph
49 d a macrophage- and T-cell-mediated model of anti-glomerular basement membrane disease in STC1 transg
50 nt nephritis (APTN) is an aggressive form of anti-glomerular basement membrane disease that targets t
51 US/TTP), 8; systemic lupus erythematosus, 3; Anti-glomerular basement membrane disease, 2; oxalosis,
52 ytoplasmic antibodies-associated vasculitis, anti-glomerular basement membrane disease, and systemic
53 severe glomerulonephritis after induction of anti-glomerular basement membrane disease, with more inf
54 l approach to the treatment of patients with anti-glomerular basement membrane disease.
55 lasmic antibodies-associated vasculitis, and anti-glomerular basement membrane disease.
56 n of glomerulonephritis after induction with anti-glomerular basement membrane globulin, with enhance
57 ological characteristics during experimental anti-glomerular basement membrane glomerulonephritis (an
58 is, we compared the intensity of accelerated anti-glomerular basement membrane glomerulonephritis bet
59 ed: a diffuse type that is characteristic of anti-glomerular basement membrane glomerulonephritis, an
60 ssociated (pauci-immune) glomerulonephritis, anti-glomerular basement membrane glomerulonephritis, C3
61                                              Anti-glomerular basement membrane GN involved NET format
62                                  Accelerated anti-glomerular basement membrane GN was examined in gro
63                            We used lupus and anti-glomerular basement membrane models of nephritis to
64 ive glomerulonephritis, type I and II (MPG), anti-glomerular basement membrane nephritis (anti-GBM),
65  and dedifferentiated podocytes of mice with anti-glomerular basement membrane nephritis and in human
66                                        Using anti-glomerular basement membrane nephritis in rats, we
67                 Moreover, after induction of anti-glomerular basement membrane nephritis in young mic
68  necessary for local chemokine expression in anti-glomerular basement membrane nephritis, although th
69 /c control mice, were challenged with rabbit anti-glomerular basement membrane nephrotoxic sera (NTS)
70 is similarly upregulated in a mouse model of anti-glomerular basement membrane protein-mediated kidne
71 kidney inflammation in a macrophage-mediated anti-glomerular basement membrane reactive serum-induced
72          Compared with wild-type mice, after anti-glomerular basement membrane treatment STC1 transge
73                            In Goodpasture's (anti-glomerular basement membrane) disease, autoimmunity
74 erular neutrophil accumulation and damage in anti-glomerular basement membrane-induced (anti-GBM-indu
75                              Similarly, both anti-glomerular basement membrane-induced glomerulonephr
76 ntaneous chronic glomerulonephritis (GN) and anti-glomerular basement membrane-induced nephritis.
77    In rats, intrarenal arterial injection of anti-glomerular endothelial cell (GEN) antibodies leads